NuVasive To Settle Medtronic Spinal Patent Suit
This article was originally published in The Gray Sheet
Executive Summary
The spinal device manufacturer is paying $45m to put the dispute to bed – less than half of a 2011 jury award.
You may also be interested in...
Earnings Winners And Losers: BSX, BCR, NUVA, NVCR
Several big names in medtech announced their second-quarter sales and earnings in late July and early August. Here are some of the companies that impressed investors and others that raised some doubts.
Court Wants To Reassess Damages In NuVasive/Medtronic Patent Fight
In a long-standing patent fight between NuVasive and Medtronic, an appeals court has ruled NuVasive was being penalized twice for lost profits based on damages awarded by a jury. The judges unanimously agreed to send the case back to a district court to reevaluate how much Medtronic should be paid.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.